Retrieval of Patient Information After Discontinuation

Amyloid Imaging And Safety Study Of Subcutaneous Bapineuzumab In Subjects With Mild to Moderate Alzheimer's Disease

NCT01254773 ·Status: COMPLETED ·Phase: PHASE2

Study Evaluating The Efficacy And Safety Of Bapineuzumab In Alzheimer Disease Patients

NCT00667810 ·Status: TERMINATED ·Phase: PHASE3

Bapineuzumab in Patients With Mild to Moderate Alzheimer's Disease (ApoE4 Carrier)

NCT00575055 ·Status: COMPLETED ·Phase: PHASE3

Study Evaluating the Safety and Efficacy of Bapineuzumab in Alzheimer Disease Patients

NCT00676143 ·Status: TERMINATED ·Phase: PHASE3

AAB-001 (Bapineuzumab) Open-Label, Long-Term Extension Study in Patients With Mild to Moderate Alzheimer's Disease

NCT00606476 ·Status: TERMINATED ·Phase: PHASE2

A Study to Evaluate the Impact of MABT5102A on Brain Amyloid Load and Related Biomarkers in Patients With Mild to Moderate Alzheimer's Disease

NCT01397578 ·Status: COMPLETED ·Phase: PHASE2

A FDG-PET Study of AGN-242071 Added to Standard-of-Care (Donepezil ± Memantine) for the Treatment of Participants With Mild to Moderate Alzheimer's Disease

NCT03316898 ·Status: WITHDRAWN ·Phase: PHASE1

A Study of Aducanumab in Participants With Mild Cognitive Impairment Due to Alzheimer's Disease or With Mild Alzheimer's Disease Dementia to Evaluate the Safety of Continued Dosing in Participants With Asymptomatic Amyloid-Related Imaging Abnormalities

NCT03639987 ·Status: TERMINATED ·Phase: PHASE2

Open Label Extension Study Evaluating Safety and Tolerability of AAB-003 (PF-05236812) in Subject With Mild to Moderate Alzheimer's Disease

NCT01369225 ·Status: COMPLETED ·Phase: PHASE1

Phase 2 Study of BIIB092 in Participants With Early Alzheimer's Disease

NCT03352557 ·Status: TERMINATED ·Phase: PHASE2

Biodistribution of [11C]PIB in Patients With Risk Factors for Alzheimer's Disease

NCT03089827 ·Status: ENROLLING_BY_INVITATION

An Extension To The B1451027 Protocol To Evaluate The Long Term Safety And Tolerability Of Dimebon In Patients With Alzheimer's Disease

NCT00939783 ·Status: TERMINATED ·Phase: PHASE3

AAB-001 in Patients With Mild to Moderate Alzheimer's Disease

NCT00112073 ·Status: COMPLETED ·Phase: PHASE2

Study of Combination Therapy With Dimebon and Donepezil (Aricept) in Patients With Alzheimer's Disease

NCT00704782 ·Status: TERMINATED ·Phase: PHASE2

A Study to Verify the Clinical Benefit of Aducanumab in Participants With Early Alzheimer's Disease

NCT05310071 ·Status: TERMINATED ·Phase: PHASE3

Amyloid Imaging And Safety Study Of ACC-001 In Subjects With Mild to Moderate Alzheimer's Disease

NCT01284387 ·Status: COMPLETED ·Phase: PHASE2

The Swedish BioFINDER 2 Study

NCT03174938 ·Status: RECRUITING ·Phase: NA

Amyloid Imaging And Safety Study Of ACC-001 In Subjects With Early Alzheimer's Disease

NCT01227564 ·Status: COMPLETED ·Phase: PHASE2

Study of ASN51 in Adults With Early Alzheimer's Disease

NCT06677203 ·Status: TERMINATED ·Phase: PHASE2

A Study of the Safety, Pharmacokinetics, Pharmacodynamics, and Immunogenicity of Anti-Abeta (MABT5102A) in Patients With Alzheimer's Disease

NCT00736775 ·Status: COMPLETED ·Phase: PHASE1

The Safety and Efficacy of an Investigational Drug in Delaying the Progression of Alzheimer's Disease

NCT00006187 ·Status: TERMINATED ·Phase: PHASE3

An Efficacy, and Safety Study Of BXCL501 For The Treatment Of Agitation Associated With Dementia

NCT05276830 ·Status: TERMINATED ·Phase: PHASE2

An Observational Study of Aducanumab-avwa in Participants With Alzheimer's Disease in the US

NCT05097131 ·Status: TERMINATED

A Study to Evaluate Safety and Tolerability of Aducanumab in Participants With Alzheimer's Disease Who Had Previously Participated in the Aducanumab Studies 221AD103, 221AD301, 221AD302 and 221AD205

NCT04241068 ·Status: TERMINATED ·Phase: PHASE3

Follow-up Study to Assess Safety and Clinical Activity of Continued AFFITOPE® AD02 Vaccinations of Patients Who Participated in AFF006

NCT02008513 ·Status: TERMINATED ·Phase: PHASE2